Manufacturing
Post# of 148168
Pourhassan says, he will be flying to South Korea to meet with the company that is producing CytoDyn's flagship drug leromlimab, Samsung BioLogics Co.
So, my thoughts are and seeing Nadar's face is it may be possible that Samsung is already prepared to support and fulfill our needs. They are definitely big enough and expanding. Once we have FDA approval, is it possible they are ready?